Capricor Therapeutics | CAPR - Dochód Netto

Cena Akcji
28.79
Dzienna Zmiana
-1.02 -3.42%
Miesięcznie
-16.77%
Rocznie
204.98%
Q2 Prognozy TE
28.21




Dochód Netto Zmiana Data
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Bioline Rx USD -977K 2.96M 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cipla INR 6.76B 6.75B 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Geron USD -3.64M 27.5M 2026-03
Grifols EUR 114.37M 34.03M 2025-12
Immunic USD -19.3M 6.28M 2025-12
J&J USD 5.24B 119M 2026-03
Plus Therapeutics USD -5.71M 1.29M 2025-12
Prothena USD -21.59M 14.95M 2025-12
PTC Therapeutics USD -2.81M 132.16M 2026-03
Sarepta Therapeutics USD 330.96M 743.18M 2026-03